Cases 1 - 10 of 79
Rounds v. GlaxoSmithKline, LLC et al
as 1:2024cv00217
Plaintiff:
David Rounds
Defendant:
GlaxoSmithKline, LLC, Pfizer, Inc., Boehringer Ingelheim Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Notice of Removal
Cusick v. GlaxoSmithKline, LLC et al
as 1:2024cv00215
Plaintiff:
Gaylon Cusick
Defendant:
GlaxoSmithKline, LLC, Pfizer, Inc., Boehringer Ingelheim Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Notice of Removal
Campion v. Pfizer, Inc. et al
as 1:2024cv00214
Plaintiff:
Renee F. Campion
Defendant:
Pfizer, Inc., Boehringer Ingelheim USA Corporation, Sanofi-Aventis U.S. LLC and others
Cause Of Action: 28 U.S.C. § 1441 Notice of Removal-Personal Injury
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Ajanta Pharma Limited
as 1:2023cv00847
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Ajanta Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Ajanta Pharma Limited
as 1:2023cv00849
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Ajanta Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Boehringer Ingelheim Corporation et al
as 1:2023cv00848
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Ajanta Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Anobri Pharmaceuticals US, LLC et al
as 1:2023cv00715
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Defendant:
Anobri Pharmaceuticals US, LLC, NanChang Anovent Pharmaceutical Co., Ltd., Shaghai Anovent Pharmaceutical Co., Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Anobri Pharmaceuticals US, LLC et al
as 1:2023cv00716
Plaintiff:
Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH
Defendant:
Anobri Pharmaceuticals US, LLC, NanChang Anovent Pharmaceutical Co., Ltd. and Shanghai Anovent Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Apotex Inc. et al
as 1:2023cv00685
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and others
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Hetero USA Inc. et al
as 1:2023cv00048
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and others
Defendant:
Hetero USA Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
